|
MindMed is a clinical-stage biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including psilocybin, LSD, MDMA, DMT and an ibogaine derivative, 18-MC.
|
|
Small Pharma is a biotechnology company researching and developing short-duration psychedelics with supportive therapy for mental health conditions.
|
|
COMPASS is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Its first programme is researching how COMP360 psilocybin therapy could help people with treatment-resistant depression.
|